Identification of ferroptosis related biomarkers and immune infiltration in Parkinson’s disease by integrated bioinformatic analysis

Table 4 Demographic and clinical characteristics of the PD patients and healthy controls used in this study

Variable	PD (n = 70)	HC (n = 39)	p value
Age, years	65.42(8.85)	63.38(9.03)	0.254
Male/female ratio	41/29	25/14	0.571
Disease duration, years	7.16(3.94)
H&Y stage, off (1\|1.5\|2\|2.5\|3\|4\|5\|)	5\|7\|10\|8\|28\|10\|2
MDS-UPDRS III “off” (0-132)	48.94(18.64)
WBC, 10^9/L	6.09(2.09)	6.29(1.15)	0.064
Neutrophils (%)	62.28(10.90)	59.03(6.63)	0.202
Lymphocyte (%)	29.14(9.66)	32.18(6.77)	0.084
Monocytes (%)	6.19(2.15)	6.02(1.35)	0.972
N/L	2.87(2.94)	1.97(0.68)	0.121
M/L	0.24(0.15)	0.19(0.07)	0.031
RBC, 10¹²/L	4.37(0.48)	4.78(0.40)	0.000
Hb, g/L	133.97(13.98)	145.38(11.76)	0.000
Hct, L/L	0.402(0.04)	0.440(0.033)	0.000

Values are means ± SD unless otherwise stated. PD, Parkinson’s disease; HC, healthy controls; H&Y stage, Hoehn and Yahr scale; MDS-UPDRS III, Movement Disorders Society-Unified Parkinson Disease Rating Scale, motor part; N/L, neutrophils/lymphocyte; M/L, monocytes/ lymphocyte

ISSN: 1755-8794